We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+11.79%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$121B
AUM Growth
+$23.8B
(+25%)
Cap. Flow
+$14B
Cap. Flow
% of AUM
11.54%
Top 10 Holdings %
Top 10 Hldgs %
11.79%
Holding
3,434
New
284
Increased
1,844
Reduced
1,127
Closed
142
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Monster Beverage
MNST
|
+$345M |
| 2 |
PNC Financial Services
PNC
|
+$325M |
| 3 |
Edison International
EIX
|
+$249M |
| 4 |
Veeva Systems
VEEV
|
+$241M |
| 5 |
Expedia Group
EXPE
|
+$239M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$300M |
| 2 |
Comcast
CMCSA
|
+$255M |
| 3 |
Airbnb
ABNB
|
+$201M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$177M |
| 5 |
Eli Lilly
LLY
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25% |
| 2 | Financials | 15.05% |
| 3 | Consumer Discretionary | 12.44% |
| 4 | Healthcare | 12.08% |
| 5 | Industrials | 11.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Aveanna Healthcare
AVAH
$1.95B
| $140K | ﹤0.01% |
26,681
+401
| +2% | +$2.04K |
|
3127
TAL Education Group
TAL
$6.78B
| $138K | ﹤0.01% |
13,551
-5,991
| -31% | -$61.9K |
|
|
TERN
3128
DELISTED
Terns Pharmaceuticals
TERN
| $138K | ﹤0.01% |
+36,974
| New | +$115K |
|
3129
Trevi Therapeutics
TRVI
$2.51B
| $136K | ﹤0.01% |
24,830
-2,890
| -10% | -$18K |
|
|
AOMR
3130
Angel Oak Mortgage REIT
AOMR
$210M
| $135K | ﹤0.01% |
+14,358
| New | +$130K |
|
3131
Theravance Biopharma
TBPH
$877M
| $135K | ﹤0.01% |
12,249
+979
| +9% | +$9.52K |
|
3132
EverCommerce
EVCM
$1.74B
| $134K | ﹤0.01% |
+12,779
| New | +$129K |
|
3133
BRC Inc
BRCC
$213M
| $133K | ﹤0.01% |
101,889
+45,028
| +79% | +$83.3K |
|
|
BIOA
3134
BioAge Labs
BIOA
$492M
| $130K | ﹤0.01% |
+31,552
| New | +$127K |
|
3135
Pure Cycle
PCYO
$274M
| $129K | ﹤0.01% |
+12,073
| New | +$125K |
|
|
DFTX
3136
Definium Therapeutics
DFTX
$5.47B
| $128K | ﹤0.01% |
19,758
+7,508
| +61% | +$49.4K |
|
|
LAZR
3137
DELISTED
Luminar Technologies
LAZR
| $128K | ﹤0.01% |
44,617
-78,668
| -64% | -$299K |
|
3138
Heron Therapeutics
HRTX
$58.9M
| $128K | ﹤0.01% |
61,749
+34,440
| +126% | +$70.3K |
|
3139
SIGA Technologies
SIGA
$208M
| $126K | ﹤0.01% |
+19,356
| New | +$116K |
|
3140
Compass Therapeutics
CMPX
$412M
| $126K | ﹤0.01% |
+48,451
| New | +$99.9K |
|
3141
Blink Charging
BLNK
$86.8M
| $125K | ﹤0.01% |
132,791
-751,619
| -85% | -$600K |
|
3142
W&T Offshore
WTI
$586M
| $125K | ﹤0.01% |
75,620
-45,291
| -37% | -$66.8K |
|
3143
Mistras Group
MG
$601M
| $125K | ﹤0.01% |
15,566
-52,478
| -77% | -$441K |
|
3144
SkinHealth Systems
SKIN
$86.3M
| $125K | ﹤0.01% |
65,199
+35,227
| +118% | +$49.6K |
|
3145
Fulcrum Therapeutics
FULC
$285M
| $124K | ﹤0.01% |
18,053
+445
| +3% | +$2.38K |
|
3146
Skye Bioscience
SKYE
$19M
| $122K | ﹤0.01% |
29,138
+17,887
| +159% | +$37K |
|
3147
Lifetime Brands
LCUT
$222M
| $122K | ﹤0.01% |
+23,829
| New | +$88.6K |
|
3148
Fennec Pharmaceuticals
FENC
$437M
| $119K | ﹤0.01% |
14,312
+3,415
| +31% | +$23.4K |
|
3149
ProFrac Holding
ACDC
$994M
| $119K | ﹤0.01% |
+15,273
| New | +$100K |
|
3150
ProKidney
PROK
$330M
| $117K | ﹤0.01% |
198,338
+145,768
| +277% | +$113K |
|
Similar funds
VGA
AQR Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, AQR Capital Management held 3,434 positions worth $121B, up 25% from $97.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
AQR Capital Management deployed $14B of net new capital in Q2 2025, opening 284 new positions and adding to 1,844 existing holdings. Its largest new stake was Reddit: 531,663 shares worth $80.1M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was ConocoPhillips, an estimated $300M trimmed.
- AQR Capital Management's largest Q2 2025 buy was Reddit: 531,663 shares worth $80.1M.
- AQR Capital Management added most to Monster Beverage in Q2 2025, an estimated $345M increase.
- AQR Capital Management's biggest Q2 2025 reduction was ConocoPhillips, cutting an estimated $300M.
- AQR Capital Management fully exited Discover Financial Services in Q2 2025, selling an estimated $36.3M.
- AQR Capital Management's ten largest holdings make up 12% of its $121B portfolio in Q2 2025.
- AQR Capital Management opened 284 new positions and closed 142 in Q2 2025.
- AQR Capital Management's portfolio value rose 25% quarter-over-quarter to $121B.
Based on AQR Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.